BIO issues white paper on comparative effectiveness
In a new paper, the Biotechnology Industry Organization reveals it has reservations about the use of comparative effectiveness in reviewing products.
The Biotechnology Industry Organization has issued a white paper on comparative effectiveness. Authored by BIO's director of economic policy Ted Buckley, Ph.D., the document maintains that while comparative effectiveness is a helpful tool for healthcare decision-makers when comparing different products, it cannot be used to provide one-size-fits-all answers. The report can be found on
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
